Xiangxue Pharmaceutical's low P/S ratio may be due to declin...
Xiangxue Pharmaceutical's low P/S ratio may be due to declining revenue and expectations of this trend continuing, potentially disappointing shareholders. Significant share price movement seems unlikely given current circumstances and recent revenue trends.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000026838e3a0aabf7.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment